Abstract
Multiple comorbidities are among the most important challenges today because comorbidity is age-related and the population is aging1. In patients with rheumatoid arthritis (RA), the risk of both fragility fractures (FF) and cardiovascular (CV) manifestations is elevated2,3,4,5, but are these comorbidities separate processes, or are they interrelated? If these events (partly) share a common pathogenesis, an FF is not only a strong risk factor for a subsequent fracture6, but also for a CV event. As a consequence, it might be useful to determine the CV risk after a recent fracture. The study by Ni Mhuircheartaigh, et al 7 brings up exciting data that show that CV risk, both of myocardial infarction (MI) and heart failure, is elevated after an FF in patients with RA. In an observational study in Olmsted County (USA) from 1995 to 2007, 1171 patients with incident RA and 1171 controls were included. At baseline, the patients had hypertension, obesity, and dyslipidemia more often, but RA patients with a previous event were excluded. During followup, 406 and 346 FF were observed, and 286 and … Address correspondence to Prof. W.F. Lems, Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, VU University Medical Center, 3A 64 Postbox 7057, 1007 MB, Amsterdam, the Netherlands. E-mail: wf.lems{at}vumc.nl
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.